PLOD1 and polycystic ovary syndrome: Neurokinin receptor antagonists could play a role in the treatment of polycystic ovary syndrome (PCOS), a prevalent endocrine disorder characterized by hyperandrogenism and an elevated LH-to-FSH ratio [51].